{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:13:21Z","timestamp":1771661601870,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Medication error (ME) surveillance in Danish healthcare relies on the mandatory national incident reporting system, the Danish Patient Safety Database (DPSD). Individual case reviews and descriptive statistics with frequency counts are the most often used approaches when analyzing MEs in incident reporting systems, including the DPSD. However, incident reporting systems often generate a large number of reports and may suffer from underreporting; consequently, additional approaches are needed to overcome these challenges. Disproportionality analysis (DPA) is a statistical tool used for signal detection of adverse drug reactions in pharmacovigilance reports, but the evidence for using DPA on ME analysis in safety reporting systems is limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to test the feasibility of DPA by analysing harmful MEs reported to DPSD 2014\u20132018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We utilized proportional reporting ratios (PRR) to identify signals of diproportionality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified well\u2010known high\u2010risk medicines, including anticoagulants, opioids, insulins, antiepileptic, and antipsychotic drugs, and their association with several ME types and stages in a medication process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>DPA might be suggested as an additional tool for screening MEs and identifying priority areas for further investigation in safety reporting systems.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.5735","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:50:07Z","timestamp":1707990607000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying high\u2010risk medications and error types in Danish patient safety database using disproportionality analysis"],"prefix":"10.1002","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-8366","authenticated-orcid":false,"given":"Olga","family":"Tchijevitch","sequence":"first","affiliation":[{"name":"Research Unit OPEN, Department of Clinical Research University of Southern Denmark  Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren F.","family":"Birkeland","sequence":"additional","affiliation":[{"name":"Research Unit OPEN, Department of Clinical Research University of Southern Denmark  Odense Denmark"},{"name":"Forensic Mental Health Research Unit Middelfart (RFM), Department of Regional Health Research, Faculty of Health Science University of Southern Denmark  Denmark"},{"name":"Psychiatric Department Middelfart Mental Health Services in the Region of Southern Denmark  Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren B.","family":"Bogh","sequence":"additional","affiliation":[{"name":"Research Unit OPEN, Department of Clinical Research University of Southern Denmark  Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-8708","authenticated-orcid":false,"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Pharmacy and Environmental Medicine University of Southern Denmark  Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"The third WHO Global Patient Safety Challenge: Medication Without Harm","author":"WHO","year":"2017"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913\u2010017\u20102605\u20105"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs\u20102019\u2010010206"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102020\u2010002298"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536800\u2010000000000\u201000000"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811435489"},{"key":"e_1_2_11_8_1","volume-title":"Dansk Patientsikkerhedsdatabase \u00e5rsberetning","author":"Styrelsen for Patientsikkerhed","year":"2021"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431\u2010017\u20103023\u20108"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2011.04166.x"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.10.013"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.587193"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1553-7250(08)34006-9"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.14335"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100258"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886310666150729112903"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12947"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2024"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1550069"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13846"},{"key":"e_1_2_11_22_1","unstructured":"Patientombuddet.\u00c5rsrapport 2012."},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018\u2010200932020\u201000003"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2011.04037.x"},{"key":"e_1_2_11_25_1","unstructured":"Stata Statistical Software: Release 17.College Station TX: StataCorp LLC."},{"key":"e_1_2_11_26_1","unstructured":"Komit\u00e9loven \u00a7 14. Danske Love.2023.https:\/\/danskelove.dk\/komit%C3%A9loven\/14"},{"key":"e_1_2_11_27_1","unstructured":"Risikosituationsl\u00e6gemidler \u2013 Styrelsen for Patientsikkerhed.2023.https:\/\/stps.dk\/da\/laering\/risikoomraader\/risikosituationslaegemidler\/"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010010\u20100986\u2010z"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12473"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.307"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq\u20102020\u2010000949"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.11\u20101\u201028"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096\u2010020\u201001057\u20106"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocv096"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010023\u201001346\u20109"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1323"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.5735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:53:24Z","timestamp":1709524404000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.5735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1002\/pds.5735"],"URL":"https:\/\/doi.org\/10.1002\/pds.5735","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"2023-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e5735"}}